Structure-based design of SARS-CoV-2 papain-like protease inhibitors-Reference-Cited by-同舟云学术

Structure-based design of SARS-CoV-2 papain-like protease inhibitors

Published:2024-01 Issue: Volume:264 Page:116011
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Jadhav Prakash,Huang Bo,Osipiuk Jerzy,Zhang Xiaoming,Tan Haozhou,Tesar Christine,Endres Michael,Jedrzejczak Robert,Tan Bin,Deng Xufang,Joachimiak Andrzej,Cai Jianfeng,Wang Jun^ORCID

Funder

Office of Science

National Institutes of Health

Argonne National Laboratory

U.S. Department of Energy

Oklahoma Center for the Advancement of Science and Technology

U.S. Department of Health and Human Services

National Institute of Food and Agriculture

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference50 articles.

1. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat. Rev. Microbiol.,2021

2. Therapeutic strategies for COVID-19: progress and lessons learned;Li;Nat. Rev. Drug Discov.,2023

3. SARS-CoV-2 main protease drug design, assay development, and drug resistance studies;Tan;Acc. Chem. Res.,2023

4. The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations;Joyce;Med. Chem. Res.,2022

5. SARS-CoV-2 antiviral therapy;Tao;Clin. Microbiol. Rev.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel quinoline papain-like protease inhibitors for COVID-19 through topology constrained molecular generative model;2024-09-09

2. On the dual role of (+)-catechin as primary antioxidant and inhibitor of viral proteases;Computers in Biology and Medicine;2024-09

3. Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure–activity relationships;Bioorganic & Medicinal Chemistry;2024-09

4. Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity;Journal of Medicinal Chemistry;2024-08-05

5. Viral deubiquitinating proteases and the promising strategies of their inhibition;Virus Research;2024-06